Last updated on January 2020

An Open-Label Randomised Active Controlled Multi-Centre Phase 3 Study to Evaluate the Safety and Efficacy of Danaparoid vs Argatroban in Treatment of Subjects With Acute HIT


Find a site near you

Start Over